For the full year, Van Hembergen reported $4.715 billion in revenue (6% reported growth) and said organic constant-currency revenue growth was 7% for 2025. Full-year adjusted EBITDA was $901 million and adjusted EPS was $0.94 , up from $0.91 in 2024. Full-year adjusted gross margin of 54.9% was flat versus 2024, as price and volume benefits were offset by inflation and higher manufacturing costs.Adjusted EBITDA was $189 million , up 7% year over year. Adjusted EPS was $0.13 , down 7%, which Van Hembergen at ...

Achieved 9% organic constant currency revenue growth in Q4, marking 10 consecutive quarters of underlying growth led by U.S. farm and pet health sectors. Innovation revenue reached $892 million in 2025, outperforming expectations due to the rapid adoption of the 'Big Six' products, particularly Credelio Quattro and Zenrelia. Credelio Quattro has become the fastest blockbuster in company history, gaining significant share in the $1.4 billion U.S. broad-spectrum parasiticide market through its unique fo ...